Enanta Pharmaceuticals
ENTA
ENTA
156 hedge funds and large institutions have $928M invested in Enanta Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 63 increasing their positions, 48 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
156
Holders Change
-15
Holders Change %
-8.77%
% of All Funds
3.45%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
19
Increased
63
Reduced
48
Closed
33
Calls
$2.32M
Puts
$3.15M
Net Calls
-$828K
Net Calls Change
-$3.77M
Top Buyers
| 1 |
KAM
1
Krensavage Asset Management
New York
|
$36M |
| 2 |
AC
2
Armistice Capital
New York
|
$29.2M |
| 3 |
3
Renaissance Technologies
New York
|
$45.3M |
| 4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$13.5M |
| 5 |
5
Ameriprise
Minneapolis,
Minnesota
|
$10.7M |
Top Sellers
| 1 |
1
Janus Henderson Group
London,
United Kingdom
|
$0 |
| 2 |
2
Morgan Stanley
New York
|
$3.51M |
| 3 |
MCM
3
Matarin Capital Management
New York
|
$0 |
| 4 |
4
Invesco
Atlanta,
Georgia
|
$12.2M |
| 5 |
5
First Manhattan
New York
|
$21.2M |
